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Introduction:  Pedal edema is a common adverse effect of dihydropyridine calcium channel blockers (CCBs). The addition of a RAS blocker, either 
an ACE inhibitor (ACEi) or an angiotensin receptor blocker (ARB), has been shown to reduce pedal edema in a dose dependent way.
Methods: We performed a MEDLINE/COCHRANE search for all the randomized controlled trials (RCTs) comparing CCBs monotherapy to 
combination with ACEi and ARBs from 1960 to present. RCTs in patients with hypertension specifying the incidence of pedal edema and having total 
sample size more than 100 patients were included in our analysis. Effect estimates were pooled across studies using random-effects meta-analysis 
and heterogeneity was assessed using the I2 statistics.
Results: We analyzed 15 RCTs with 11,081 patients, mean age 56±6 years, 53% males, and the mean duration 9.3 weeks. Incidence of edema 
with CCB monotherapy was 11.9 % compared to 8.3% with CCB/RAS combination (p <0.0001). Similarly the patient withdrawal due to edema was 
higher with CCBs (2.6%) than with CCB/RAS combinations (0.7%) (p=0.002). Incidence of edema with CCB/ARB combination (9.3%) was 1.6 times 
higher than with CCB/ACEi combination (6%) (p=0.0001).
Conclusion: The combination of either ACEis or ARBs with CCBs reduces the incidence and withdrawal rate 
of pedal edema. ACE inhibitors are more efficacious in reducing CCB associated pedal edema than are ARBs.
